Skip to main content

REVIEW article

Front. Pharmacol.

Sec. Gastrointestinal and Hepatic Pharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1467950

The Role of Hepatic Sinusoidal Microenvironment in NASH: Pathogenesis, Animal Models, and Therapeutic Prospects

Provisionally accepted
Wanying Tan Wanying Tan 1Jiangting Deng Jiangting Deng 2Lingjun Qi Lingjun Qi 3Zhenghuai Tan Zhenghuai Tan 2*
  • 1 West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
  • 2 Sichuan Academy of Traditional Chinese Medicine, Chengdu, China
  • 3 Affiliated Sichuan Gem Flower Hospital of North Sichuan Medical College, Chengdu, Sichuan Province, China

The final, formatted version of the article will be published soon.

    The incidence of nonalcoholic steatohepatitis (NASH) is increasing annually, posing a significant threat to human health.NASH is typified by hepatic steatosis, inflammation, and hepatocellular injury, frequently culminating in fibrosis and cirrhosis. Yet, the precise pathogenesis of NASH remains to be fully elucidated. The hepatic sinusoid, which serves as the fundamental structural and functional unit of the liver, is intricately composed of endothelial cells, Kupffer cells, and hepatic stellate cells. Consequently, the homeostasis of the hepatic sinusoidal microenvironment may exert a pivotal influence on the progression and prognosis of NASH. However, the limitations of current NASH animal models have significantly impeded advancements in understanding the disease's pathogenesis and in the development of effective therapeutic interventions. In light of these challenges, this review endeavors to delve deeper into the critical role of hepatic sinusoidal microenvironment homeostasis in the pathogenesis of NASH, critically analyze the commonly employed animal models, and comprehensively summarize the most recent and promising developments in drug research and development. It is anticipated that these efforts will collectively expedite the advancement of the field of NASH research and therapeutic innovation.

    Keywords: nonalcoholic steatohepatitis, Pathogenesis, animal model, Drug Development, hepatic sinusoid microenvironment

    Received: 21 Jul 2024; Accepted: 28 Mar 2025.

    Copyright: © 2025 Tan, Deng, Qi and Tan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Zhenghuai Tan, Sichuan Academy of Traditional Chinese Medicine, Chengdu, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more